297 related articles for article (PubMed ID: 16949645)
21. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.
Watari J; Das KK; Amenta PS; Tanabe H; Tanaka A; Geng X; Lin JJ; Kohgo Y; Das KM
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):409-17. PubMed ID: 18321787
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori and intestinal metaplasia.
Evrensel T; Manavoğlu O; Ozyardimci C; Gülten M; Nak SG; Yerci O
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):215-9. PubMed ID: 9216809
[TBL] [Abstract][Full Text] [Related]
23. Changes in aberrant DNA methylation after Helicobacter pylori eradication: a long-term follow-up study.
Shin CM; Kim N; Lee HS; Park JH; Ahn S; Kang GH; Kim JM; Kim JS; Lee DH; Jung HC
Int J Cancer; 2013 Nov; 133(9):2034-42. PubMed ID: 23595635
[TBL] [Abstract][Full Text] [Related]
24. Risk factors associated with the development of intestinal metaplasia in first-degree relatives of gastric cancer patients.
Leung WK; Ng EK; Chan WY; Auyeung AC; Chan KF; Lam CC; Chan FK; Lau JY; Sung JJ
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2982-6. PubMed ID: 16365021
[TBL] [Abstract][Full Text] [Related]
25. The non-invasive diagnosis of precancerous changes of stomach mucosa.
Pasechnikov VD; Chukov SZ; Kotelevets SM; Mostovov AN; Polyakova MB; Mernova VP
Rocz Akad Med Bialymst; 2004; 49():66-71. PubMed ID: 15631316
[TBL] [Abstract][Full Text] [Related]
26. [Gastric dysplasia: its incidence in precancerous conditions, advanced cancer and early cancer].
Hojman D; Cenoz MC; Even L; Puzzo MA
Acta Gastroenterol Latinoam; 1988; 18(4):231-48. PubMed ID: 3255219
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of leptin as marker for patients at high risk of gastric cancer.
Capelle LG; de Vries AC; Haringsma J; Steyerberg EW; Looman CW; Nagtzaam NM; van Dekken H; ter Borg F; de Vries RA; Kuipers EJ
Helicobacter; 2009 Dec; 14(6):596-604. PubMed ID: 19889078
[TBL] [Abstract][Full Text] [Related]
28. The gastric mucosa in gastric cancer patients in a low-incidence area.
Genta RM; Pusztaszeri M
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1085-93. PubMed ID: 16957515
[TBL] [Abstract][Full Text] [Related]
29. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
[TBL] [Abstract][Full Text] [Related]
30. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration.
Sakitani K; Hirata Y; Watabe H; Yamada A; Sugimoto T; Yamaji Y; Yoshida H; Maeda S; Omata M; Koike K
J Gastroenterol Hepatol; 2011 Oct; 26(10):1570-5. PubMed ID: 21575058
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn?
de Vries AC; Kuipers EJ; Rauws EA
Am J Gastroenterol; 2009 Jun; 104(6):1342-5. PubMed ID: 19491846
[TBL] [Abstract][Full Text] [Related]
32. Cell kinetic balance in gastric mucosa with intestinal metaplasia after Helicobacter pylori eradication: 2-year follow-up study.
Wambura C; Aoyama N; Shirasaka D; Kuroda K; Watanabe Y; Miki I; Tamura T; Kasuga M
Dig Liver Dis; 2004 Mar; 36(3):178-86. PubMed ID: 15046186
[TBL] [Abstract][Full Text] [Related]
33. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
34. Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela.
Kato I; Vivas J; Plummer M; Lopez G; Peraza S; Castro D; Sanchez V; Cano E; Andrade O; Garcia R; Franceschi S; Oliver W; Muñoz N
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):468-76. PubMed ID: 15006925
[TBL] [Abstract][Full Text] [Related]
35. Topographic patterns of intestinal metaplasia and gastric cancer.
Cassaro M; Rugge M; Gutierrez O; Leandro G; Graham DY; Genta RM
Am J Gastroenterol; 2000 Jun; 95(6):1431-8. PubMed ID: 10894575
[TBL] [Abstract][Full Text] [Related]
36. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
[TBL] [Abstract][Full Text] [Related]
37. Intestinal metaplasia and dysplastic modifications in H. pylori gastritis.
Tăban S; Tudose N
Rom J Morphol Embryol; 1996; 42(1-2):109-15. PubMed ID: 9038394
[TBL] [Abstract][Full Text] [Related]
38. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
[TBL] [Abstract][Full Text] [Related]
39. Detection of cardia intestinal metaplasia: do the biopsy number and location matter?
Sharma P; McElhinney C; Topalovski M; Mayo MS; McGregor DH; Weston A
Am J Gastroenterol; 2004 Dec; 99(12):2424-8. PubMed ID: 15571591
[TBL] [Abstract][Full Text] [Related]
40. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
